Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest announcement is out from Enhabit, Inc ( (EHAB) ).
On February 12, 2026, Enhabit, Inc. announced that, together with Encompass Health Corporation, it has collected $43.1 million in full satisfaction of claims for attorneys’ fees and mitigation damages in a Delaware Court of Chancery case. The payment was obtained from former officer Chris Walker, Vistria Group senior partner David Schuppan, and Nautic Partners managing director Christopher Corey, following a December 2024 judgment finding egregious breaches of the duty of loyalty by several former senior officers.
Under the same Delaware ruling, the court imposed a constructive trust granting Enhabit and Encompass Health a 43% share of VitalCaring Group’s ongoing profits and exit proceeds if the business is sold, to be split between the two companies. The settlement secures a meaningful cash recovery for both firms while leaving intact the constructive trust order against other defendants, potentially providing additional financial upside and reinforcing legal accountability for fiduciary misconduct in the home health and hospice sector.
The most recent analyst rating on (EHAB) stock is a Hold with a $11.50 price target. To see the full list of analyst forecasts on Enhabit, Inc stock, see the EHAB Stock Forecast page.
Spark’s Take on EHAB Stock
According to Spark, TipRanks’ AI Analyst, EHAB is a Neutral.
Enhabit, Inc’s overall stock score is driven by mixed financial performance, with profitability challenges offset by strong cash flow improvements. Technical indicators show positive momentum, while valuation remains a concern due to negative earnings. The earnings call and corporate events provide optimism with strategic growth initiatives and improved financial guidance, but potential regulatory risks remain.
To see Spark’s full report on EHAB stock, click here.
More about Enhabit, Inc
Enhabit, Inc., operating as Enhabit Home Health & Hospice, is a leading national provider of home health and hospice services in the United States. The company delivers technology-enabled, in-home clinical care through a network of 247 home health locations and 115 hospice locations across 34 states, focusing on supporting patients and families where they are most comfortable.
Enhabit leverages advanced technology and multidisciplinary clinical teams to deliver what it describes as extraordinary patient care in the home setting. Its nationwide footprint positions the company as a significant player in the growing home-based care market, serving a broad geographic and demographic patient base while competing with other major post-acute and hospice providers.
Average Trading Volume: 449,673
Technical Sentiment Signal: Buy
Current Market Cap: $566.3M
For a thorough assessment of EHAB stock, go to TipRanks’ Stock Analysis page.